Meeting the Challenge of Antimicrobial Resistance in Cirrhosis: The Invisible Threat That Lies Within

Gastroenterology. 2021 Aug;161(2):413-415. doi: 10.1053/j.gastro.2021.05.043. Epub 2021 May 25.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Drug Resistance, Bacterial* / drug effects
  • Health Policy
  • Humans
  • Liver Cirrhosis / drug therapy

Substances

  • Anti-Bacterial Agents